What is the size of the Genomic Biomarkers market in 2023?

The Genomic Biomarkers market size is USD 7.1 Billion in 2023.

What is the projected CAGR at which the Genomic Biomarkers market is expected to grow at?

The Genomic Biomarkers market is expected to grow at a CAGR of 9.1% (2024-2033).

List the segments encompassed in this report on the Genomic Biomarkers market?

Market.US has segmented the Genomic Biomarkers market by geographic (North America, Europe, APAC, South America, and Middle East and Africa). By Type the market has been segmented into Predictive Biomarkers and Prognostic Biomarkers. By Disease Indication the market has been segmented into Oncology, Neurological Diseases, Renal Disorders, Cardiovascular Diseases, and Other Disease Indications. By End-User the market has been segmented into Hospitals, Diagnostic, Research Laboratories, and, Other End-Users.

List the key industry players of the Genomic Biomarkers market?

Bio-Rad Laboratories, Almac Group, Eurofins Scientific, Cancer Genetics Inc, Thermo Fisher Scientific Inc, Epigenomics AG, US Biomarkers Inc., Myriad Genetics, Aepodia SA, Roche Diagnostics, Other Key Players

Which region is more appealing for vendors employed in the Genomic Biomarkers market?

North America is expected to account for the highest revenue share with 32%, and boasting an impressive market value of USD 2.2 Billion. Therefore, the Genomic Biomarkers industry in North America is expected to garner significant business opportunities over the forecast period.

Name the key areas of business for Genomic Biomarkers?

The US, Canada, India, China, UK, Japan, & Germany are key areas of operation for the Genomic Biomarkers Market.

Genomic Biomarkers Market By Type (Predictive Biomarkers and Prognostic Biomarkers), By Disease Indication (Oncology, Neurological Diseases, Renal Disorders, Cardiovascular Diseases, and Other Disease Indications) By End-User (Hospitals, Diagnostic, Research Laboratories, and, Other End-Users), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: July 2024
Report ID: 124487
Number of Pages: 306
Format:

- Bio-Rad Laboratories, Inc. Company Profile
- Almac Group
- Eurofins Scientific
- Cancer Genetics Inc
- Thermo Fisher Scientific Company Profile
- Epigenomics AG
- US Biomarkers Inc.
- Myriad Genetics
- Aepodia SA
- Roche Diagnostics
- Other Key Players
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 124487
Published Date July 2024
Rating
- ★★★★★
  
  ★★★★★
- (85)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)